Form 4 for MIST Milestone Pharmaceuticals Inc.
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-31 · accession 0001209191-22-033336 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-31 | MIST | TRUEX PAUL F | Dir | P - Purchase | $5.60 | +5,000 | 81.8K | +7% | +$28.0K |
| DM | 2022-06-01 | 2022-05-31 | MIST | TRUEX PAUL F | Dir | M - OptEx | $1.51 | +76.8K | 8,016 | New | +$115.8K |
| DM | 2022-06-01 | 2022-05-31 | MIST | TRUEX PAUL F | Dir | M - OptEx | $0.00 | -76.8K | 117 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-05-31 | P | A | 5,000 | $5.60 | 81,780 | D | — | — | |
| 2 | Common | Common Shares | 2022-05-31 | M | A | 822 | $2.66 | 76,780 | D | — | — | |
| 3 | Common | Common Shares | 2022-05-31 | M | A | 22,870 | $1.54 | 75,958 | D | — | — | |
| 4 | Common | Common Shares | 2022-05-31 | M | A | 45,072 | $1.54 | 53,088 | D | — | — | |
| 5 | Common | Common Shares | 2022-05-31 | M | A | 8,016 | $1.12 | 8,016 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2022-05-31 | M | D | 22,870 | $0.00 | 2,659 | D | $1.54 · — to 2028-10-15 | 22,870 Common Shares | (F2) Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. |
| 7 | Derivative | Stock Option (right to buy) | 2022-05-31 | M | D | 8,016 | $0.00 | 0 | D | $1.12 · — to 2025-08-26 | 8,016 Common Shares | (F1) Fully vested and exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2022-05-31 | M | D | 45,072 | $0.00 | 0 | D | $1.54 · — to 2027-07-21 | 45,072 Common Shares | (F1) Fully vested and exercisable. |
| 9 | Derivative | Stock Option (right to buy) | 2022-05-31 | M | D | 822 | $0.00 | 117 | D | $2.66 · — to 2028-11-20 | 822 Common Shares | (F3) Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. |